Aviva’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,072
Closed -$1.05M 999
2021
Q2
$1.05M Hold
6,072
﹤0.01% 808
2021
Q1
$1.09M Buy
+6,072
New +$1.12M 0.01% 895
2020
Q2
Sell
-22,316
Closed -$3.37M 956
2020
Q1
$3.37M Buy
22,316
+12,672
+131% +$2.46M 0.02% 630
2019
Q4
$2.02M Buy
+9,644
New +$1.89M 0.01% 698

Other funds holding MSGS

Aviva's MSGS Position: Q3 2021 in Review

Aviva sold out of Madison Square Garden (MSGS) in Q3 2021, closing a stake of 6,072 shares — an estimated $1.05M sold.

Aviva first reported a position in MSGS in Q4 2019 and held it in 4 quarters. The position peaked at $3.37M in Q1 2020. 258 funds tracked by Wall St. Rank hold MSGS as of Q3 2021.

  • Aviva reported no remaining Madison Square Garden position as of Q3 2021 after selling out during the quarter.
  • Aviva sold 6,072 Madison Square Garden shares in Q3 2021, an estimated $1.05M.
  • Aviva first reported a position in Madison Square Garden in Q4 2019 and held it in 4 quarters.
  • Aviva's Madison Square Garden position peaked at $3.37M in Q1 2020.
  • 258 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2021.

Based on Aviva's 13F filing for Q3 2021, filed 12 Nov 2021.